NCT01980797View on ClinicalTrials.gov

International Bicuspid Aortic Valve Consortium (BAVCon)

Active, not recruitingOBSERVATIONAL
Enrollment

10,000

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2028

Study Completion Date

November 30, 2028

Conditions
Bicuspid Aortic Valve DiseaseThoracic Aortic Disease in Patients With a Bicuspid Aortic Valve
Trial Locations (12)

20097

Istituto Policlinico San Donato, San Donato Milanese

48109

University of Michigan, Ann Arbor

55905

Mayo Clinic, Rochester

77030

University of Texas Health Science Center at Houston, Houston

80100

Monaldi Hospital, Naples

80131

Second University of Naples, Naples

02111

Tufts Medical Center, Boston

02218

Boston Medical Center, Boston

G1V 4G5

Laval University, Québec

36-83023

University of Salerno, Salerno

08035

Hospital Vall d'Hebron, Barcelona

OX3 9DU

University of Oxford, Oxford

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Boston University

OTHER

NCT01980797 - International Bicuspid Aortic Valve Consortium (BAVCon) | Biotech Hunter | Biotech Hunter